Karyometric analysis of actinic damage in unexposed and sun-exposed skin and in actinic keratoses in untreated individuals

Analytical and Quantitative Cytology and Histology

Volumn 26, Issue 3, 2004, Pages 155-165

  Ranger Moore, James ^a,b   Bartels, Peter H ^a,b   Bozzo, Paul ^a,b   Einspahr, Janine ^a,c   Liu, Yun ^a,b   Saboda, Kathylynn ^a,b   Alberts, David S ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Optical Sciences Center ^*  (United States)

Author keywords

Actinic keratosis; Disease progression; Karyometry; Keratosis; Skin cancer

Indexed keywords

SOLBAR PF50 CREAM; SUNSCREEN;

ACTINIC KERATOSIS; ADULT; ARTICLE; CANCER PREVENTION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; KARYOMETRY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN CANCER; SUN EXPOSURE;

ACTINS; ADOLESCENT; BIOPSY; COHORT STUDIES; FEMALE; HUMANS; KARYOMETRY; KERATOSIS; MALE; SKIN; SUNLIGHT; SUNSCREENING AGENTS; TIME FACTORS;

EID: 2942542669     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27
2. Kwa RE, Campana K, Moy RL: Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;26:1-26
3. Moller RF, Reymann F, Hou-Jensen K: Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol 1979;115:703-705
4. Kanzler MH: An estimate of the annual cost of treating cutaneous melanoma. J Am Acad Dermatol 1999;41:281-283
5. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC: Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials. Cancer Res (suppl) 1994;54:2015s-2024s
6. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK: Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 1990;82:555-560
7. Wied GL, Bartels PH, Bibbo M: Cytomorphometric markers for uterine cancer in intermediate cells. Analyt Quant Cytol 1980;2:257-263
8. Bibbo M, Bartels PH, Sychra JJ, Wied GL: Chromatin appearance in intermediate cells from patients with uterine cancer. Acta Cytol 1981;25:23-28
9. Haroske G, Bergander ST, Koenig R, Meyer W: Application of malignancy associated changes of the cervical epithelium in a hierarchic classification concept. Analyt Cell Pathol 1990;2:189-198
10. MacAulay C, Lam S, Payne PW, LeRiche JC, Palcic B: Malignancy associated changes in bronchial epithelial cells in biopsy specimens. Analyt Quant Cytol Histol 1995;17:55-61
11. Montag AG, Bartels PH, Dytch HE, Lerma-Puertas E, Michelassi F, Bibbo M: Karyometric features in nuclei near colonic adenocarcinoma: Statistical analysis. Analyt Quant Cytol Histol 1991;13:159-167
12. Bibbo M, Michelassi F, Bartels PH, Dytch H, Bania C, Lerma E, Montag AG: Karyometric marker features in normal appearing glands adjacent to human colonic adenocarcinoma. Cancer Res 1990;50:147-151
13. Bibbo M, Bartels PH, Galera-Davidson H, Dytch H, Wied GL: Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors. Analyt Quant Cytol Histol 1986;8:168-176
14. Susnik B, Worth A, LeRiche J, Palcic B: Malignancy-associated changes in the breast: Changes in chromatin distribution in epithelial cells in normal-appearing tissue adjacent to carcinoma. Analyt Quant Cytol Histol 1995;17:62-68
15. Sherman AB, Koss LG: Morphometry of benign urothelial cells in the presence of cancer (abstr). Analyt Quant Cytol Histol 1983;5:221
16. Irinopolou T, Rigaut JP, Benson MC: Towards objective prognostic grading of prostatic carcinoma using image analysis. Analyt Quant Cytol Histol 1993;15:341-344
17. Bozzo PD, Vaught LC, Alberts DS, Thompson D, Bartels PH: Nuclear morphometry in solar keratosis. Analyt Quant Cytol Histol 1998;20:21-28
18. Galloway M: Texture analysis using gray level run lengths. Comput Graphics Image Proc 1975;4:172-179
19. Young T, Verbeek PW, Mayall B: Characterization of chromatin distributions in cell nuclei. Cytometry 1986;7:467-474
20. Bartels PH, daSilva VD, Montironi R, Hamilton PW, Thompson D, Vaught L, Bartels HG: Chromatin texture signatures in nuclei from prostate lesions. Analyt Quant Cytol Histol 1998;20:407-416
21. SAS Institute, Inc: SAS/STAT Software: Changes and Enhancements, Release 8.1. Cary, North Carolina, SAS Institute Inc, 2000
22. Bartels PH, Montironi RM, Bostwick D, Marshall J, Thompson D, Bartels HG, Kelley D: Karyometry of secretory cell nuclei in high grade PIN lesions. Prostate 2001;48:144-155
23. Einspahr JG, Alberts DS, Gapstur SM, Bostick RM, Emerson SS, Gerner EW: Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev 1997;6:37-48